Indication
Focal Seizure
1 clinical trial
2 products
Product
CenobamateClinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label ExtensionStatus: Active (not recruiting), Estimated PCD: 2024-02-01
Product
Placebo